While evidence suggests that aberrant GABAergic signaling can influence cancer cell proliferation and migration, further studies are necessary to determine whether KCTD12 and KCTD16 contribute to OC pathogenesis via alternative mechanisms, such as modulating intracellular calcium homeostasis or interacting with non‐neuronal signaling pathways [65, 66]. The gene discussed is KCTD12; the disease is cancer.